2020 SEP 06 Studies show HCQ cuts (Virus Mortality in Half in High Risk Groups)
Yale University Professor Harvey Risch; Use In High Risk People And We Would See: 3/4 (75%) REDUCTION in DEATHS. all studies that examine the effectiveness of hydroxychloroquine on high risk population groups show the drug is “uniformly beneficial” in treating COVID-19. Continue Reading